CNTA NASDAQ
Centessa Pharmaceuticals plc
1W: +0.8%
1M: +1.7%
3M: +41.1%
YTD: +71.0%
1Y: +210.6%
3Y: +537.8%
5Y: +63.6%
$40.50
Last traded 2026-06-29 — delisted
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Supply Chain
Supply Chain Overview
3 relationships3
As Filer
counterparties named
0
As Counterparty
mentioned by others
2
Rel. Types
2025-02-21
Earliest Filing
2026-03-31
Latest Filing
acquirer: 2
partner: 1
Counterparties (Filed by CNTA)
3 relationshipsCompanies named in CNTA's SEC 8-K filings as business counterparties.
| Counterparty | Ticker | Relationship | Summary | Filing Date | SEC |
|---|---|---|---|---|---|
| Eli Lilly and Company | LLY | acquirer | Parent company acquiring Centessa Pharmaceuticals plc via a scheme of arrangement | 2026-03-31 | View |
| LDH XV Corporation | — | acquirer | Direct wholly owned subsidiary of Eli Lilly and Company executing the acquisition of Centessa Pharmaceuticals plc | 2026-03-31 | View |
| Genmab A/S | GNMSF | partner | Entered into a License Agreement with Centessa to leverage the LockBody platform for research and potential commercializ | 2025-02-21 | View |
Recent 8-K Filings (20)
| Filing Date | Description | Type | SEC |
|---|---|---|---|
| 2026-06-24 | Termination of Agreement; Acquisition/Disposition; Delisting Notice; Change in Control; Officer/Dire | Acquisition | View |
| 2026-06-12 | Shareholder Vote; Other Events | View | |
| 2026-05-22 | Other Events | View | |
| 2026-03-31 | Material Agreement; Regulation FD; Exhibits | Agreement | View |
| 2026-02-13 | Departure/Election of Directors; Appointment of Officers | View | |
| 2026-01-07 | Departure/Election of Directors; Appointment of Officers; Financial Statements and Exhibits | View | |
| 2025-12-11 | Departure/Election of Directors; Appointment of Officers; Regulation FD Disclosure; Financial Statem | View | |
| 2025-11-24 | Other Events; Financial Statements and Exhibits | View | |
| 2025-11-13 | Entry into Material Definitive Agreement; Other Events; Financial Statements and Exhibits | Agreement | View |
| 2025-11-05 | Results of Operations and Financial Condition; Regulation FD Disclosure; Financial Statements and Ex | View | |
| 2025-08-12 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-06-20 | Submission of Matters to a Vote of Security Holders | View | |
| 2025-06-17 | Other Events; Financial Statements and Exhibits | View | |
| 2025-05-29 | Departure/Election of Directors; Appointment of Officers; Financial Statements and Exhibits | View | |
| 2025-05-14 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-03-24 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-02-21 | Entry into Material Definitive Agreement | Agreement | View |
| 2025-01-08 | Regulation FD Disclosure; Financial Statements and Exhibits | View | |
| 2024-12-30 | Entry into Material Definitive Agreement; Termination of Material Definitive Agreement; Creation of | Agreement | View |
| 2024-11-12 | Results of Operations and Financial Condition; Regulation FD Disclosure; Financial Statements and Ex | View |
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text.
Covers 2021–2026. View on SEC EDGAR